Tempus AI's growth and partnerships make it an attractive investment. See why TEM stock is a solid Buy due to its ...

We recently compiled a list of the 10 AI News You Shouldn’t Miss. In this article, we are going to take a look at where ...

Aliso Viejo-based Ambry Genetics Corp. on Nov. 4 announced an agreement to be acquired for $600 million by Tempus AI Inc.

Fintel reports that on November 11, 2024, Stifel downgraded their outlook for Tempus AI (NasdaqGS:TEM) from Buy to Hold. ...

Stifel Nicolaus analyst Daniel Arias downgraded the rating on Tempus AI, Inc. Class A (TEM – Research Report) to a Hold yesterday, ...

Stifel downgraded Tempus AI (TEM) to Hold from Buy with a price target of $65, up from $45. The stock is up 100% since its debut and Tempus ...

With Ambry Genetics in tow, Eric Lefkofsky's biotech startup hopes to accelerate its drive toward turning a profit.

CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...

In addition, please check the fund’s top five holdings to know its best picks in 2024. Baron Discovery Fund highlighted ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today reported financial results for the ...

周二，Piper Sandler调整了对Tempus AI Inc (NASDAQ:TEM)的展望，将该人工智能公司的股票目标价从此前的40美元上调至70美元。该公司维持对Tempus AI股票的中性评级。此次调整是在Tempus AI最近发布财报后做出的，财报是修订估值的一个因素。 Piper Sandler的分析师将财报作为上调目标价的主要原因。尽管做出了积极调整，但分析师指出，新的目标价并未 ...

周二，Piper Sandler调整了对Tempus AI Inc (NASDAQ:TEM)的展望，将目标价从此前的$40.00上调至$70.00。尽管做出了这一重大调整，但该公司仍维持对该股票的中性评级。 此次调整是在Tempus AI最近发布财报之后进行的，这份财报似乎提供了新的数据，促使分析师重新评估公司的股票价值。Piper Sandler的分析师注意到了公司的积极表现，但并未改变先前持有 ...